Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of genotypic resistance in untreated HIV patients in Spain.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology - 1 Apr 2002

Eiros J M, Labayru C, Hernández B, Ortega M, Bachiller P, Ortiz de Lejarazu R

Abstract excerpt

The aims of this retrospective study were to assess the prevalence of primary genotypic resistance to antiretroviral drugs in untreated HIV patients in Spain using the line probe assay and to determine its possible relationship to several epidemiological variables. The global prevalence of primary resistance was 12.5%. Primary mutations in the reverse transcriptase gene were found in two (2.2%) samples: M41L,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Variation

Share to HIV Infections

Share to HIV Reverse Transcriptase

Share to Mutation

Source

Identifiers

PMID: 12072945
DOI: 10.1007/s10096-002-0711-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of genotypic resistance in untreated HIV patients in Spain.PMID 12072945Read ↗

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.Semantic proximity Read ↗

Prevalence of genotypic resistance in untreated HIV-infected patients.Semantic proximity Read ↗

[Prevalence of antiretroviral drug genotypic resistance among HIV patients in Cuenca, Spain].Semantic proximity Read ↗

[Prevalence of primary antiretroviral resistance among HIV infected patients in Chile].Semantic proximity Read ↗

Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.Semantic proximity Read ↗

[Primary antiretroviral drug resistance among patients diagnosed with HIV infection in Gran Canaria (Spain) between 2002 and 2005].Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in SpainSemantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.Semantic proximity Read ↗

Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.Semantic proximity Read ↗

Single- and multidrug resistance mutations to reverse transcriptase and protease inhibitors: human immunodeficiency virus type 1-infected patients from two geographical areas in Spain. Spanish Groups for Antiretroviral Resistance Studies.Semantic proximity Read ↗

Emergence of antiretroviral drug resistance in therapy-naive HIV infected patients in Hungary.Semantic proximity Read ↗

Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.